| NCT03390985 |
Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor |
https://ClinicalTrials.gov/show/NCT03390985 |
Completed |
The Hospital for Sick Children |
2017-07-26 |
| NCT03381157 |
Fidgety Movements in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03381157 |
Completed |
Hacettepe University |
2019-02-02 |
| NCT03377686 |
Breath Analysis in Children by New Point-of-care Instruments |
https://ClinicalTrials.gov/show/NCT03377686 |
Completed |
Maastricht University Medical Center |
2017-11-30 |
| NCT03577756 |
Neurodevelopmental Assessment of Infants With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03577756 |
Recruiting |
Hacettepe University |
2019-12-12 |
| NCT03820752 |
Vaccination Coverage and Level of Protection in Patients at Risk |
https://ClinicalTrials.gov/show/NCT03820752 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2017-06-30 |
| NCT03820349 |
Cystic Fibrosis and Cognitive Function |
https://ClinicalTrials.gov/show/NCT03820349 |
Recruiting |
University of Minnesota |
2021-04-30 |
| NCT03338595 |
Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF |
https://ClinicalTrials.gov/show/NCT03338595 |
Active, not recruiting |
Augusta University |
2020-05-31 |
| NCT03335202 |
Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03335202 |
Recruiting |
University of Kiel |
2019-09-30 |
| NCT03323983 |
Exploratory Study on Link Between Dynamic Hyperinflation and Lung Clearance Index in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03323983 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2016-11-30 |
| NCT03320382 |
Multiple Breath Washout, a Clinimetric Dataset |
https://ClinicalTrials.gov/show/NCT03320382 |
Recruiting |
Imperial College London |
2021-03-31 |
| NCT03318328 |
Evaluation of Food Insecurity in Adults and Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03318328 |
Completed |
St. Luke’s Health System, Boise, Idaho |
2015-03-31 |
| NCT03298685 |
SAFETIM-needs : Exploring Adolescent’s and Parent’s Needs During Transition in French CF Centers |
https://ClinicalTrials.gov/show/NCT03298685 |
Completed |
University Hospital, Grenoble |
2018-12-31 |
| NCT03265743 |
HPV Vaccination in Women With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03265743 |
Completed |
Hospices Civils de Lyon |
2017-12-15 |
| NCT03256773 |
High Resolution Micro OCT Imaging |
https://ClinicalTrials.gov/show/NCT03256773 |
Recruiting |
University of Alabama at Birmingham |
2020-12-31 |
| NCT03229213 |
Interactive Video Game Responses in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03229213 |
Completed |
Pontificia Universidade Católica do Rio Grande do Sul |
2019-03-31 |
| NCT03161808 |
Rare CFTR Mutation Cell Collection Protocol (RARE) |
https://ClinicalTrials.gov/show/NCT03161808 |
Recruiting |
University of Alabama at Birmingham |
2022-12-01 |
| NCT03052283 |
Symptom Score to Assess Abdominal Involvement in Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03052283 |
Recruiting |
University of Jena |
2020-12-31 |
| NCT03016689 |
The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development |
https://ClinicalTrials.gov/show/NCT03016689 |
Recruiting |
University of Minnesota |
2021-01-31 |
| NCT03001388 |
Longitudinal Assessment of Transient Elastography in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03001388 |
Active, not recruiting |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2022-12-31 |
| NCT02979340 |
MRI to Characterize and Predict CF Liver Disease in PUSH Cohort |
https://ClinicalTrials.gov/show/NCT02979340 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2019-12-31 |
| NCT02958683 |
Chest Wall Motion Analysis in Disease |
https://ClinicalTrials.gov/show/NCT02958683 |
Completed |
Heart of England NHS Trust |
2015-07-31 |
| NCT02932657 |
Perceived Impact of Art Therapy in Patients With Cystic Fibrosis and in Professional Interdisciplinary Teams Taking Care of Them. |
https://ClinicalTrials.gov/show/NCT02932657 |
Completed |
Nantes University Hospital |
2018-01-28 |
| NCT02894619 |
Urinary and Anorectal Functional Disorders and Their Impact on CF Adults (PerineoMucoRMO) |
https://ClinicalTrials.gov/show/NCT02894619 |
Completed |
Fondation Ildys |
2018-02-28 |
| NCT02864446 |
Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction |
https://ClinicalTrials.gov/show/NCT02864446 |
Completed |
Seoul National University Hospital |
2015-09-30 |
| NCT02853175 |
Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02853175 |
Completed |
Hôpital Haut-Lévêque |
2018-05-31 |
| NCT02848560 |
Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI |
https://ClinicalTrials.gov/show/NCT02848560 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-12-31 |
| NCT02847208 |
Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02847208 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02832479 |
Costs of Care and Adherence to Treatment for Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02832479 |
Completed |
Hospices Civils de Lyon |
2016-02-29 |
| NCT02821130 |
Orkambi Exercise Study |
https://ClinicalTrials.gov/show/NCT02821130 |
Active, not recruiting |
University of British Columbia |
2019-12-31 |
| NCT02807415 |
ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor |
https://ClinicalTrials.gov/show/NCT02807415 |
Recruiting |
Hannover Medical School |
2019-09-30 |
| NCT02803944 |
Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years |
https://ClinicalTrials.gov/show/NCT02803944 |
Completed |
Hospices Civils de Lyon |
2015-09-30 |
| NCT02797912 |
LBM & Lung Function in Adolescents With CF |
https://ClinicalTrials.gov/show/NCT02797912 |
Completed |
King’s College Hospital NHS Trust |
2017-08-31 |
| NCT02778750 |
Evaluation Of The Pan-microbiome and Host Immune Response in CF |
https://ClinicalTrials.gov/show/NCT02778750 |
Recruiting |
NYU Langone Health |
2023-11-30 |
| NCT02776098 |
Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance |
https://ClinicalTrials.gov/show/NCT02776098 |
Active, not recruiting |
Children’s Hospital of Philadelphia |
2020-12-31 |
| NCT02722057 |
A Study to Confirm the Long-term Safety and Effectiveness of Kalydeco in Patients With Cystic Fibrosis Who Have an R117H-CFTR Mutation, Including Pediatric Patients |
https://ClinicalTrials.gov/show/NCT02722057 |
Completed |
Vertex Pharmaceuticals Incorporated |
2019-12-31 |
| NCT02710383 |
Biomarker for Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02710383 |
Recruiting |
Centogene AG Rostock |
2023-12-31 |
| NCT02693431 |
Impact of Art Therapy on Anxiety Identified During Hospitalizations Among Children With Cystic Fibrosis Aged 8 to 13 |
https://ClinicalTrials.gov/show/NCT02693431 |
Completed |
Nantes University Hospital |
2018-11-27 |
| NCT02684422 |
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF) |
https://ClinicalTrials.gov/show/NCT02684422 |
Recruiting |
University of North Carolina, Chapel Hill |
2020-12-31 |
| NCT02657837 |
Measures of Respiratory Health (MRH) |
https://ClinicalTrials.gov/show/NCT02657837 |
Recruiting |
The Hospital for Sick Children |
2021-12-31 |
| NCT02606487 |
Hyperpolarized Xenon MRI in Cystic Fibrosis Pulmonary Exacerbations |
https://ClinicalTrials.gov/show/NCT02606487 |
Completed |
The Hospital for Sick Children |
2017-11-30 |
| NCT00001223 |
Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders |
https://ClinicalTrials.gov/show/NCT00001223 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02569229 |
Glucose Tolerance in Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02569229 |
Active, not recruiting |
University Hospital, Basel, Switzerland |
2018-09-30 |
| NCT02564393 |
Induction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02564393 |
Completed |
University Hospital, Tours |
2013-05-31 |
| NCT02562911 |
Puberty in Girls Followed for Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02562911 |
Completed |
University Hospital, Toulouse |
2015-12-31 |
| NCT03795363 |
Orkambi Treatment in 2 to 5 Year Old Children With CF |
https://ClinicalTrials.gov/show/NCT03795363 |
Active, not recruiting |
Children’s Hospital of Philadelphia |
2021-06-30 |
| NCT02558127 |
Asthma With Hypersecretion-associated Gene for Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02558127 |
Completed |
Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau |
2016-02-29 |
| NCT02555059 |
Special Drug Use Investigation of Ciproxan Injection in Pediatrics |
https://ClinicalTrials.gov/show/NCT02555059 |
Completed |
Bayer |
2018-12-17 |
| NCT02524704 |
Electrical Impedance Imaging of Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02524704 |
Completed |
Colorado State University |
2016-12-31 |
| NCT02480270 |
Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation |
https://ClinicalTrials.gov/show/NCT02480270 |
Completed |
University of Colorado, Denver |
2017-01-04 |
| NCT02477319 |
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT) |
https://ClinicalTrials.gov/show/NCT02477319 |
Completed |
University of Alabama at Birmingham |
2018-04-25 |
| NCT02464267 |
Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation in CF |
https://ClinicalTrials.gov/show/NCT02464267 |
Completed |
University of Zurich |
2017-09-30 |
| NCT02445053 |
Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study) |
https://ClinicalTrials.gov/show/NCT02445053 |
Active, not recruiting |
Vertex Pharmaceuticals Incorporated |
2020-12-31 |
| NCT02417740 |
Natural History of Noncirrhotic Portal Hypertension |
https://ClinicalTrials.gov/show/NCT02417740 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2029-09-04 |
| NCT02378454 |
Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children |
https://ClinicalTrials.gov/show/NCT02378454 |
Completed |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2015-04-30 |
| NCT02368080 |
Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults |
https://ClinicalTrials.gov/show/NCT02368080 |
Completed |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2013-12-31 |
| NCT02363764 |
The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT02363764 |
Completed |
Universitair Ziekenhuis Brussel |
2016-08-31 |
| NCT02305784 |
Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT02305784 |
Completed |
Institut de Recherches Cliniques de Montreal |
2018-06-01 |
| NCT02288429 |
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium |
https://ClinicalTrials.gov/show/NCT02288429 |
Completed |
University of Colorado, Denver |
2019-06-30 |
| NCT02270476 |
Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening |
https://ClinicalTrials.gov/show/NCT02270476 |
Recruiting |
Heidelberg University |
2021-12-31 |
| NCT02229994 |
Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases |
https://ClinicalTrials.gov/show/NCT02229994 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-03-27 |
| NCT02225899 |
BioEnergetics and Metabolomics in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02225899 |
Completed |
Emory University |
2018-11-07 |
| NCT02211235 |
Glycemic Monitoring in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02211235 |
Active, not recruiting |
University of Colorado, Denver |
2020-12-31 |
| NCT02203084 |
Social Determinants in Chronic Disease in British Columbia |
https://ClinicalTrials.gov/show/NCT02203084 |
Completed |
University of British Columbia |
2017-06-01 |
| NCT02198079 |
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida |
https://ClinicalTrials.gov/show/NCT02198079 |
Completed |
University of Miami |
2015-03-31 |
| NCT02188758 |
Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment |
https://ClinicalTrials.gov/show/NCT02188758 |
Completed |
Dartmouth-Hitchcock Medical Center |
2017-12-31 |
| NCT02179710 |
Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study |
https://ClinicalTrials.gov/show/NCT02179710 |
Completed |
Landon Pediatric Foundation |
2016-09-30 |
| NCT02141464 |
Energy Balance and Weight Gain With Ivacaftor Treatment |
https://ClinicalTrials.gov/show/NCT02141464 |
Completed |
Children’s Hospital of Philadelphia |
2016-02-29 |
| NCT02128711 |
Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens |
https://ClinicalTrials.gov/show/NCT02128711 |
Recruiting |
University of Minnesota |
2020-07-31 |
| NCT02109822 |
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF |
https://ClinicalTrials.gov/show/NCT02109822 |
Completed |
University of Washington |
2015-06-30 |
| NCT02073409 |
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis |
https://ClinicalTrials.gov/show/NCT02073409 |
Recruiting |
National Jewish Health |
2023-03-31 |
| NCT01306279 |
The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective |
https://ClinicalTrials.gov/show/NCT01306279 |
Completed |
Imperial College London |
2012-08-31 |
| NCT01285895 |
Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT01285895 |
Completed |
Nantes University Hospital |
2013-10-31 |
| NCT01285882 |
Representations of Transplantation in Patients and in Health Care Professionals |
https://ClinicalTrials.gov/show/NCT01285882 |
Completed |
Nantes University Hospital |
2012-12-31 |
| NCT02056132 |
Breath Condensate Study in Patients With Cystic Fibrosis. |
https://ClinicalTrials.gov/show/NCT02056132 |
Recruiting |
University of Florida |
2020-04-30 |
| NCT02039986 |
Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF) |
https://ClinicalTrials.gov/show/NCT02039986 |
Completed |
Children’s Hospital of Philadelphia |
2016-10-11 |
| NCT03357913 |
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03357913 |
Completed |
Hospices Civils de Lyon |
2017-06-01 |
| NCT02003079 |
Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02003079 |
Completed |
St. Paul’s Hospital, Canada |
2014-03-31 |
| NCT01983787 |
Pharmacokinetics of Piperacillin, Given as Continuous Infusion to Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01983787 |
Completed |
University of Aarhus |
2015-06-30 |
| NCT02025829 |
IL-17 Neutrophils in CF Lung Inflammation |
https://ClinicalTrials.gov/show/NCT02025829 |
Completed |
University Hospitals Cleveland Medical Center |
2014-12-31 |
| NCT01975259 |
Investigating the Incretin Effect in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01975259 |
Completed |
Liverpool Heart and Chest Hospital NHS Foundation Trust |
2015-07-31 |
| NCT01973192 |
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT01973192 |
Completed |
Indiana University |
2016-12-01 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT01883037 |
Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT |
https://ClinicalTrials.gov/show/NCT01883037 |
Completed |
Royal Brompton & Harefield NHS Foundation Trust |
2014-04-30 |
| NCT01863238 |
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01863238 |
Completed |
Vertex Pharmaceuticals Incorporated |
2016-05-31 |
| NCT01858519 |
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy |
https://ClinicalTrials.gov/show/NCT01858519 |
Completed |
AbbVie |
2016-09-30 |
| NCT01852448 |
Genetics of Insulin and Incretins in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01852448 |
Active, not recruiting |
Children’s Hospital of Philadelphia |
2024-07-31 |
| NCT01851642 |
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs |
https://ClinicalTrials.gov/show/NCT01851642 |
Recruiting |
University of Florida |
2020-09-30 |
| NCT01848392 |
Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients. |
https://ClinicalTrials.gov/show/NCT01848392 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-07-30 |
| NCT01832519 |
Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF |
https://ClinicalTrials.gov/show/NCT01832519 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2017-01-09 |
| NCT03350828 |
CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes |
https://ClinicalTrials.gov/show/NCT03350828 |
Recruiting |
Seattle Children’s Hospital |
2021-01-01 |
| NCT01815866 |
Cough-Generated Aerosols of NTM in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01815866 |
Completed |
University of Florida |
2015-07-31 |
| NCT01806025 |
Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT01806025 |
Completed |
Carmel Medical Center |
2015-01-31 |
| NCT01799642 |
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01799642 |
Completed |
University of British Columbia |
2014-12-31 |
| NCT01736839 |
Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution |
https://ClinicalTrials.gov/show/NCT01736839 |
Completed |
National Jewish Health |
2017-07-27 |
| NCT01661491 |
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01661491 |
Recruiting |
Yale University |
2020-12-31 |
| NCT01652157 |
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy) |
https://ClinicalTrials.gov/show/NCT01652157 |
Recruiting |
AbbVie |
2022-07-29 |
| NCT01651455 |
Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000 |
https://ClinicalTrials.gov/show/NCT01651455 |
Completed |
Chiesi Farmaceutici S.p.A. |
2013-03-31 |
| NCT01636219 |
Cough Efficiency in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01636219 |
Completed |
Sheba Medical Center |
2013-06-30 |
| NCT01626157 |
A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF) |
https://ClinicalTrials.gov/show/NCT01626157 |
Completed |
National Jewish Health |
2018-01-31 |
| NCT01616862 |
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01616862 |
Completed |
State University of New York - Upstate Medical University |
2013-06-30 |
| NCT01599052 |
Social Cognition in Children Treated for a Brain Tumour |
https://ClinicalTrials.gov/show/NCT01599052 |
Active, not recruiting |
University Medical Center Groningen |
2020-12-31 |
| NCT01572870 |
Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients |
https://ClinicalTrials.gov/show/NCT01572870 |
Completed |
Rambam Health Care Campus |
2011-03-31 |
| NCT01569880 |
Pre-flight Evaluation of Adult Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01569880 |
Completed |
Oslo University Hospital |
2008-12-31 |
| NCT01549314 |
Cystic Fibrosis Related Bone Disease: the Role of CFTR |
https://ClinicalTrials.gov/show/NCT01549314 |
Completed |
Massachusetts General Hospital |
2018-05-31 |
| NCT01521338 |
G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) |
https://ClinicalTrials.gov/show/NCT01521338 |
Active, not recruiting |
University of Alabama at Birmingham |
2021-01-31 |
| NCT01479166 |
Bronchial Inflammation of Small Airways in Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01479166 |
Completed |
Johann Wolfgang Goethe University Hospital |
2012-05-31 |
| NCT01460836 |
Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01460836 |
Completed |
Novartis |
2010-10-31 |
| NCT01424696 |
Baby Observational and Nutritional Study |
https://ClinicalTrials.gov/show/NCT01424696 |
Completed |
Seattle Children’s Hospital |
2015-04-30 |
| NCT01401998 |
UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource |
https://ClinicalTrials.gov/show/NCT01401998 |
Recruiting |
Children’s National Research Institute |
2022-09-30 |
| NCT01401439 |
Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01401439 |
Completed |
University of Arkansas |
2016-07-31 |
| NCT01375036 |
Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT01375036 |
Completed |
Gilead Sciences |
2016-12-31 |
| NCT01353950 |
Costimulatory Molecules as Biomarkers in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01353950 |
Completed |
Oregon Health and Science University |
2013-06-30 |
| NCT01345617 |
A Study of Sweat Testing Using a Quantitative Patch |
https://ClinicalTrials.gov/show/NCT01345617 |
Completed |
Polychrome Medical, Inc. |
2013-10-31 |
| NCT01343524 |
Changes in Lung Function Based on Differences in Spirometry Equipment Used in Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01343524 |
Completed |
State University of New York - Upstate Medical University |
2010-12-31 |
| NCT01331980 |
Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls |
https://ClinicalTrials.gov/show/NCT01331980 |
Completed |
University of Arkansas |
2015-07-31 |
| NCT04400955 |
A Study of Web and Tablet-based Interactive Audiometry in Adults With CF |
https://ClinicalTrials.gov/show/NCT04400955 |
Completed |
Royal Brompton & Harefield NHS Foundation Trust |
2019-03-01 |
| NCT04397861 |
T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease |
https://ClinicalTrials.gov/show/NCT04397861 |
Active, not recruiting |
National Jewish Health |
2019-05-01 |
| NCT04397809 |
Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04397809 |
Active, not recruiting |
National Jewish Health |
2019-05-23 |
| NCT04392544 |
Intestinal Inflammation in CF Patients |
https://ClinicalTrials.gov/show/NCT04392544 |
Recruiting |
The Hospital for Sick Children |
2021-03-31 |
| NCT04354038 |
Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations |
https://ClinicalTrials.gov/show/NCT04354038 |
Recruiting |
National Jewish Health |
2025-12-31 |
| NCT04341532 |
Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations |
https://ClinicalTrials.gov/show/NCT04341532 |
Recruiting |
National Jewish Health |
2023-12-31 |
| NCT04302428 |
Zinc Status and Growth in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04302428 |
Recruiting |
Indiana University |
2021-06-30 |
| NCT04301856 |
Response to CFTR Modulators in CF Patients Under 18 Years |
https://ClinicalTrials.gov/show/NCT04301856 |
Recruiting |
Societe Francaise de la Mucoviscidose |
2025-07-01 |
| NCT04256772 |
Anti-IL5 and Other Biotherapies in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04256772 |
Recruiting |
University Hospital, Montpellier |
2020-06-01 |
| NCT04225962 |
Intimacy of Women With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04225962 |
Recruiting |
Hospices Civils de Lyon |
2020-11-30 |
| NCT04206436 |
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04206436 |
Enrolling by invitation |
Indiana University |
2022-10-01 |
| NCT04217889 |
Cystic Fibrosis Adherence Study |
https://ClinicalTrials.gov/show/NCT04217889 |
Recruiting |
Hospices Civils de Lyon |
2020-07-31 |
| NCT04174664 |
Comparison of Different Functional Capacity Tests in Cystic Fibrosis Patients With Acute Pulmonary Exacerbation |
https://ClinicalTrials.gov/show/NCT04174664 |
Recruiting |
Hacettepe University |
2021-01-01 |
| NCT04171583 |
Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways |
https://ClinicalTrials.gov/show/NCT04171583 |
Recruiting |
University Hospital Muenster |
2020-05-31 |
| NCT04161313 |
Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children |
https://ClinicalTrials.gov/show/NCT04161313 |
Completed |
Bezmialem Vakif University |
2020-02-24 |
| NCT04157361 |
Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis. |
https://ClinicalTrials.gov/show/NCT04157361 |
Recruiting |
The Institute of Molecular and Translational Medicine, Czech Republic |
2020-01-31 |
| NCT04138589 |
Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function |
https://ClinicalTrials.gov/show/NCT04138589 |
Recruiting |
University Medical Center Groningen |
2021-02-01 |
| NCT04071314 |
Evaluating the Alimentary and Respiratory Tracts in Health and Disease (EARTH) Research Program. |
https://ClinicalTrials.gov/show/NCT04071314 |
Recruiting |
The University of New South Wales |
2023-03-13 |
| NCT04056702 |
Impact of Triple Combination CFTR Therapy on Sinus Disease. |
https://ClinicalTrials.gov/show/NCT04056702 |
Active, not recruiting |
National Jewish Health |
2021-04-30 |
| NCT04038710 |
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease. |
https://ClinicalTrials.gov/show/NCT04038710 |
Active, not recruiting |
National Jewish Health |
2021-02-28 |
| NCT04038047 |
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function |
https://ClinicalTrials.gov/show/NCT04038047 |
Active, not recruiting |
Seattle Children’s Hospital |
2022-11-30 |
| NCT04026360 |
Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04026360 |
Recruiting |
University Hospital Inselspital, Berne |
2050-08-31 |
| NCT04024423 |
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04024423 |
Recruiting |
National Jewish Health |
2021-07-01 |
| NCT04016571 |
Parameters to Assess Response to Intra-Venous Antibiotic Treatment for Pulmonary Exacerbations in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04016571 |
Recruiting |
Belfast Health and Social Care Trust |
2019-09-30 |
| NCT04016194 |
Prediction of Survival in Children With Cystic Fibrosis Using the Multiple-breath Washout |
https://ClinicalTrials.gov/show/NCT04016194 |
Completed |
University Hospital Inselspital, Berne |
2005-12-31 |
| NCT03961516 |
Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03961516 |
Recruiting |
University Hospitals Cleveland Medical Center |
2020-07-01 |
| NCT03910920 |
Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center. |
https://ClinicalTrials.gov/show/NCT03910920 |
Enrolling by invitation |
Queen Fabiola Children’s University Hospital |
2021-01-31 |
| NCT03902236 |
Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis |
https://ClinicalTrials.gov/show/NCT03902236 |
Recruiting |
Hacettepe University |
2019-10-07 |
| NCT03892304 |
Gynecological Health Improvement of Adult Women With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03892304 |
Completed |
Hospices Civils de Lyon |
2017-12-31 |
| NCT03886350 |
Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk) |
https://ClinicalTrials.gov/show/NCT03886350 |
Recruiting |
University Hospital, Tours |
2022-04-30 |
| NCT03859531 |
Gastrointestinal Study at Orkambi Therapy in CF Patients |
https://ClinicalTrials.gov/show/NCT03859531 |
Recruiting |
Karolinska University Hospital |
2020-06-30 |
| NCT03853629 |
Air Pollution and Children With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03853629 |
Completed |
Queen Mary University of London |
2020-01-30 |
| NCT03850145 |
Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT03850145 |
Completed |
University Hospital, Montpellier |
2019-12-01 |
| NCT03839992 |
Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03839992 |
Recruiting |
Gelb, Arthur F., M.D. |
2020-04-25 |
| NCT03801993 |
Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03801993 |
Completed |
Seattle Children’s Hospital |
2019-09-17 |
| NCT03754088 |
In Vitro Model of the Cystic Fibrosis Bronchial Epithelium Via iPS Technology |
https://ClinicalTrials.gov/show/NCT03754088 |
Completed |
University Hospital, Montpellier |
2019-04-25 |
| NCT03753828 |
Estimated Impact of Fungal Colonization in Cystic Fibrosis From Secondary Exploitation of MucoFong Database. |
https://ClinicalTrials.gov/show/NCT03753828 |
Completed |
University Hospital, Bordeaux |
2018-10-13 |
| NCT03736096 |
Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT03736096 |
Recruiting |
University Hospital, Brest |
2019-10-31 |
| NCT03728595 |
Validation of a Predictive Score for HAST |
https://ClinicalTrials.gov/show/NCT03728595 |
Recruiting |
The Leeds Teaching Hospitals NHS Trust |
2021-07-31 |
| NCT03713437 |
Measurement of Beta Cell Death in Individuals With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03713437 |
Recruiting |
University of Nebraska |
2020-06-30 |
| NCT03674216 |
Study of Peripherally Inserted Venous Catheters in Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT03674216 |
Recruiting |
Maine Medical Center |
2021-12-31 |
| NCT03670472 |
Correction of Nonsense Mutations in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03670472 |
Recruiting |
University Hospital, Lille |
2028-01-31 |
| NCT03659214 |
Impact of the Introduction of ORKAMBI on Anxiety, Depression, Quality of Life and Adherence of Adolescents and Young Adults |
https://ClinicalTrials.gov/show/NCT03659214 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2018-12-31 |
| NCT03652090 |
Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03652090 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2016-03-03 |
| NCT03684759 |
Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03684759 |
Completed |
University Hospital, Brest |
2017-02-06 |
| NCT03607396 |
Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03607396 |
Recruiting |
Hospital Universitari Vall d’Hebron Research Institute |
2019-07-01 |
| NCT03593434 |
Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI |
https://ClinicalTrials.gov/show/NCT03593434 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-07-30 |
| NCT03579173 |
Determinants of Early Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT03579173 |
Active, not recruiting |
Indiana University |
2020-04-30 |
| NCT03569904 |
Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT03569904 |
Recruiting |
University Hospital, Grenoble |
2021-09-30 |
| NCT03566550 |
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1 |
https://ClinicalTrials.gov/show/NCT03566550 |
Completed |
Nottingham University Hospitals NHS Trust |
2019-02-20 |
| NCT03565692 |
Lum-Iva-biota: Exploring the Respiratory Mycobiota and Microbiota Profile in French CF Patients Taking Lumacaftor-Ivacaftor |
https://ClinicalTrials.gov/show/NCT03565692 |
Recruiting |
University Hospital, Bordeaux |
2023-02-28 |
| NCT03524859 |
Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls. |
https://ClinicalTrials.gov/show/NCT03524859 |
Completed |
Universidad Católica San Antonio de Murcia |
2019-03-26 |
| NCT03513640 |
Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants |
https://ClinicalTrials.gov/show/NCT03513640 |
Recruiting |
Seoul National University Hospital |
2021-04-30 |
| NCT03512119 |
Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor |
https://ClinicalTrials.gov/show/NCT03512119 |
Completed |
University Hospital, Strasbourg, France |
2018-04-30 |
| NCT03494894 |
Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary Dyskinesia |
https://ClinicalTrials.gov/show/NCT03494894 |
Recruiting |
Centre Hospitalier Intercommunal Creteil |
2019-09-01 |
| NCT03445793 |
: TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva) |
https://ClinicalTrials.gov/show/NCT03445793 |
Completed |
National Jewish Health |
2019-11-01 |
| NCT03437811 |
Airway Clearance System (K031876) Phase IV Device Efficacy |
https://ClinicalTrials.gov/show/NCT03437811 |
Completed |
Mack Biotech, Corp. |
2019-11-01 |
| NCT01241890 |
Prevention of CF Exacerbation in Childhood: PREVEC Study |
https://ClinicalTrials.gov/show/NCT01241890 |
Completed |
Maastricht University Medical Center |
2013-08-31 |
| NCT01238081 |
The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults |
https://ClinicalTrials.gov/show/NCT01238081 |
Completed |
Manchester University NHS Foundation Trust |
2012-04-30 |
| NCT01150136 |
Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study |
https://ClinicalTrials.gov/show/NCT01150136 |
Completed |
University of British Columbia |
2009-03-31 |
| NCT01144507 |
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01144507 |
Active, not recruiting |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2022-11-30 |
| NCT01116414 |
Molecular Phenotypes for Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT01116414 |
Enrolling by invitation |
University of North Carolina, Chapel Hill |
2020-04-30 |
| NCT01113216 |
Genetic Modifiers of Cystic Fibrosis Related Diabetes |
https://ClinicalTrials.gov/show/NCT01113216 |
Enrolling by invitation |
Johns Hopkins University |
2025-04-30 |
| NCT01078740 |
Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects |
https://ClinicalTrials.gov/show/NCT01078740 |
Completed |
CF Therapeutics Development Network Coordinating Center |
2010-07-31 |
| NCT00943514 |
Natural History of Bronchiectasis |
https://ClinicalTrials.gov/show/NCT00943514 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00908830 |
Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients |
https://ClinicalTrials.gov/show/NCT00908830 |
Completed |
University of Michigan |
2011-05-31 |
| NCT00906568 |
Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) |
https://ClinicalTrials.gov/show/NCT00906568 |
Completed |
Johann Wolfgang Goethe University Hospital |
2010-05-31 |
| NCT00863694 |
Fecal Calprotectin in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00863694 |
Completed |
Medical College of Wisconsin |
2013-08-31 |
| NCT04353752 |
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs |
https://ClinicalTrials.gov/show/NCT04353752 |
Recruiting |
National Jewish Health |
2023-12-31 |
| NCT04335370 |
Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04335370 |
Recruiting |
University of Michigan |
2020-12-31 |
| NCT04297709 |
Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04297709 |
Completed |
Mologic Ltd |
2019-07-31 |
| NCT03783286 |
Ivacaftor Treatment in 6 Month to 2 Year Old CF Subjects |
https://ClinicalTrials.gov/show/NCT03783286 |
Active, not recruiting |
Children’s Hospital of Philadelphia |
2020-06-01 |
| NCT03622892 |
Non-invasive Prenatal Diagnosis of Monogenic Disorders by Linked-reads Technology |
https://ClinicalTrials.gov/show/NCT03622892 |
Recruiting |
University Hospital, Brest |
2021-10-18 |
| NCT02194881 |
Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation |
https://ClinicalTrials.gov/show/NCT02194881 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2016-02-29 |
| NCT03919604 |
ECMO for Lung Transplantation in Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT03919604 |
Completed |
Policlinico Hospital |
2018-12-31 |
| NCT03234387 |
A CFit Study - Baseline |
https://ClinicalTrials.gov/show/NCT03234387 |
Recruiting |
University of Portsmouth |
2020-03-31 |
| NCT01533636 |
CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment |
https://ClinicalTrials.gov/show/NCT01533636 |
Recruiting |
University of California, San Francisco |
2020-04-30 |
| NCT01379040 |
Volatile Organic Compounds in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT01379040 |
Completed |
Landon Pediatric Foundation |
2009-12-31 |
| NCT01319253 |
A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies |
https://ClinicalTrials.gov/show/NCT01319253 |
Completed |
Indiana University |
2012-07-31 |
| NCT00806455 |
Exercise-Induced Bronchospasm in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00806455 |
Completed |
Ohio State University |
2013-08-31 |
| NCT00804661 |
Sleep in Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00804661 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2009-06-30 |
| NCT00804583 |
Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease |
https://ClinicalTrials.gov/show/NCT00804583 |
Active, not recruiting |
University of North Carolina, Chapel Hill |
2021-07-31 |
| NCT00368446 |
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease |
https://ClinicalTrials.gov/show/NCT00368446 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02419989 |
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT02419989 |
Recruiting |
National Jewish Health |
2023-03-31 |
| NCT01805713 |
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung |
https://ClinicalTrials.gov/show/NCT01805713 |
Completed |
University of Minnesota |
2017-12-31 |
| NCT01488721 |
Clinical Evaluation of NeoPlex4 Assay and NeoPlex System |
https://ClinicalTrials.gov/show/NCT01488721 |
Completed |
Luminex Molecular Diagnostics |
2012-02-29 |
| NCT04402801 |
Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT04402801 |
Enrolling by invitation |
University of Virginia |
2021-05-31 |
| NCT04306939 |
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study |
https://ClinicalTrials.gov/show/NCT04306939 |
Recruiting |
University of Pittsburgh |
2025-12-01 |
| NCT00834054 |
Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted Patients |
https://ClinicalTrials.gov/show/NCT00834054 |
Completed |
Hopital Foch |
2011-07-31 |
| NCT00788359 |
Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation |
https://ClinicalTrials.gov/show/NCT00788359 |
Completed |
University of Colorado, Denver |
2012-07-31 |
| NCT00779077 |
Cystic Fibrosis (CF) Flow Rates Study |
https://ClinicalTrials.gov/show/NCT00779077 |
Completed |
Pharmaxis |
2009-02-28 |
| NCT00760071 |
Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF) |
https://ClinicalTrials.gov/show/NCT00760071 |
Completed |
German Cancer Research Center |
2008-10-31 |
| NCT00758771 |
Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents |
https://ClinicalTrials.gov/show/NCT00758771 |
Completed |
University of California, San Francisco |
2012-12-31 |
| NCT00750932 |
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00750932 |
Completed |
University Hospital, Tours |
2012-01-31 |
| NCT00727285 |
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies |
https://ClinicalTrials.gov/show/NCT00727285 |
Completed |
National Jewish Health |
2011-10-31 |
| NCT00676169 |
The EPIC Observational Study |
https://ClinicalTrials.gov/show/NCT00676169 |
Completed |
CF Therapeutics Development Network Coordinating Center |
2018-12-31 |
| NCT00670579 |
Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF) |
https://ClinicalTrials.gov/show/NCT00670579 |
Completed |
University of Florence |
2009-10-31 |
| NCT00669760 |
Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT00669760 |
Completed |
University Hospital Muenster |
2011-07-31 |
| NCT00596232 |
Investigating Mucinase Activity in Airway Disease |
https://ClinicalTrials.gov/show/NCT00596232 |
Completed |
University of California, San Francisco |
2015-12-31 |
| NCT00590330 |
Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs |
https://ClinicalTrials.gov/show/NCT00590330 |
Completed |
Boston Children’s Hospital |
2009-03-31 |
| NCT00585364 |
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA |
https://ClinicalTrials.gov/show/NCT00585364 |
Completed |
University of Pittsburgh |
2010-12-31 |
| NCT00577252 |
Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00577252 |
Completed |
Akron Children’s Hospital |
NA |
| NCT00531531 |
Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00531531 |
Completed |
University of Florence |
2008-08-31 |
| NCT00504361 |
Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) |
https://ClinicalTrials.gov/show/NCT00504361 |
Completed |
Weill Medical College of Cornell University |
2012-05-31 |
| NCT00485082 |
Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner |
https://ClinicalTrials.gov/show/NCT00485082 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-03-21 |
| NCT00457301 |
Using Health-related Quality of Life (HRQL) in Routine Clinical Care |
https://ClinicalTrials.gov/show/NCT00457301 |
Completed |
University of Alberta |
2007-04-30 |
| NCT00413140 |
Non-Invasive Biomarkers in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00413140 |
Completed |
Maastricht University Medical Center |
NA |
| NCT00381628 |
Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations |
https://ClinicalTrials.gov/show/NCT00381628 |
Completed |
University Hospitals Cleveland Medical Center |
2011-09-30 |
| NCT00362739 |
Blood Collection From Individuals With Lung Disease for Genetic Studies |
https://ClinicalTrials.gov/show/NCT00362739 |
Completed |
Weill Medical College of Cornell University |
2015-08-31 |
| NCT00360503 |
Antimicrobial Resistance in Cystic Fibrosis (CF) |
https://ClinicalTrials.gov/show/NCT00360503 |
Completed |
Seattle Children’s Hospital |
NA |
| NCT00333957 |
Capsule Endoscopy in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00333957 |
Completed |
Hadassah Medical Organization |
NA |
| NCT00323167 |
Rare Genetic Disorders of the Breathing Airways |
https://ClinicalTrials.gov/show/NCT00323167 |
Completed |
University of North Carolina, Chapel Hill |
2012-10-31 |
| NCT00311506 |
A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease |
https://ClinicalTrials.gov/show/NCT00311506 |
Completed |
Genentech, Inc. |
2004-06-30 |
| NCT00266474 |
Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00266474 |
Completed |
University of Jena |
NA |
| NCT00222508 |
The Microvascular Complications Study |
https://ClinicalTrials.gov/show/NCT00222508 |
Completed |
University of Minnesota |
NA |
| NCT00221559 |
Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group |
https://ClinicalTrials.gov/show/NCT00221559 |
Completed |
University Hospital, Ghent |
NA |
| NCT00043225 |
The Role of Bacteria and Genetic Variations in Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00043225 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00037778 |
Genetic Modifiers of Cystic Fibrosis: Sibling Study |
https://ClinicalTrials.gov/show/NCT00037778 |
Completed |
Johns Hopkins University |
2013-02-28 |
| NCT00037765 |
Gene Modifiers of Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT00037765 |
Active, not recruiting |
University of North Carolina, Chapel Hill |
2021-07-31 |
| NCT00027183 |
Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa |
https://ClinicalTrials.gov/show/NCT00027183 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00404859 |
FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00404859 |
Completed |
Maastricht University Medical Center |
NA |
| NCT00015756 |
Tissue Collection From People With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00015756 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00014781 |
Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00014781 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00008762 |
Bone Health of People With Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00008762 |
Completed |
National Center for Research Resources (NCRR) |
NA |
| NCT00004296 |
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT00004296 |
Completed |
Office of Rare Diseases (ORD) |
NA |